iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding iTeos Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 138 | 2 | 136 | 0 |
| Shares | 35.0M | 52.6K | 34.6M | −407.5K (−1.2%) |
| Value | $383.4M | $575.2K | $471.2M | +$88.4M (+23.1%) |
2 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held iTeos Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Braidwell LP | 1,162,374 | $15.9M | 0.51% |
| Acadian Asset Management LLC | 244,712 | $3.34M | 0.01% |
| Eagle Asset Management Inc | 233,584 | $3.12M | 0.02% |
| Kennedy Capital Management, Inc. | 145,734 | $1.99M | 0.04% |
| Wellington Management Group LLP | 85,854 | $1.17M | 0.00% |
| J. Goldman & Co LP | 82,153 | $1.12M | 0.05% |
| Franklin Resources Inc | 36,438 | $497.0K | 0.00% |
| Catalyst Funds Management Pty Ltd | 33,700 | $459.7K | 0.13% |
| Los Angeles Capital Management LLC | 29,398 | $401.0K | 0.00% |
| Lighthouse Investment Partners, LLC | 24,473 | $333.8K | 0.02% |
| LMR Partners LLP | 22,972 | $313.3K | 0.01% |
| Allianz Asset Management GmbH | 20,542 | $280.2K | 0.00% |
| K2 Principal Fund, L.P. | 20,000 | $272.8K | 0.07% |
| Prelude Capital Management, LLC | 17,428 | $237.7K | 0.02% |
| Point72 (DIFC) Ltd | 1,233 | $16.8K | 0.00% |
| nVerses Capital, LLC | 500 | $6.82K | 0.02% |
| Toth Financial Advisory Corp | 100 | $1.36K | 0.00% |
| Smartleaf Asset Management LLC | 35 | $460 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 5 | $68 | 0.00% |
Sold out (19)
Institutions that held iTeos Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| BVF Inc | 1,259,476 | $13.8M |
| Artal Group S.A. | 400,000 | $4.38M |
| Vontobel Holding Ltd. | 220,056 | $2.41M |
| Jump Financial, LLC | 58,056 | $635.7K |
| Laurion Capital Management LP | 50,121 | $548.8K |
| Dynamic Technology Lab Private Ltd | 47,461 | $520.0K |
| State of Wisconsin Investment Board | 44,804 | $490.6K |
| Y-Intercept (Hong Kong) Ltd | 26,430 | $289.4K |
| Jane Street Group, LLC | 23,933 | $262.1K |
| Brevan Howard Capital Management LP | 22,705 | $248.6K |
| Principal Financial Group Inc | 16,430 | $179.9K |
| Aristides Capital LLC | 14,360 | $157.2K |
| Graham Capital Management, L.P. | 14,276 | $156.3K |
| Occudo Quantitative Strategies LP | 14,073 | $154.1K |
| Corton Capital Inc. | 12,152 | $133.1K |
| Engineers Gate Manager LP | 11,880 | $130.1K |
| Man Group plc | 10,005 | $109.6K |
| Simplex Trading, LLC | 6,426 | $70.0K |
| AJOVista, LLC | 5,233 | $57.3K |
Not filed for Q1 2024 yet (2)
Institutions that held iTeos Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Putnam Investments LLC | 34,904 | $382.2K |
| NinePointTwo Capital | 17,677 | $193.0K |